Compare ARQT & FG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARQT | FG |
|---|---|---|
| Founded | 2016 | 1959 |
| Country | United States | United States |
| Employees | N/A | 1338 |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.2B |
| IPO Year | 2020 | N/A |
| Metric | ARQT | FG |
|---|---|---|
| Price | $23.68 | $24.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $34.00 | $31.00 |
| AVG Volume (30 Days) | ★ 1.1M | 687.6K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.00% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.46 | $7.94 |
| Revenue Next Year | $29.77 | $5.51 |
| P/E Ratio | ★ N/A | $8.41 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $12.42 | $20.57 |
| 52 Week High | $31.77 | $36.70 |
| Indicator | ARQT | FG |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 48.91 |
| Support Level | $22.56 | $20.97 |
| Resistance Level | $27.26 | $29.63 |
| Average True Range (ATR) | 0.95 | 1.00 |
| MACD | 0.33 | 0.12 |
| Stochastic Oscillator | 69.57 | 36.46 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.